OSAIC HOLDINGS, INC. - INMED PHARMACEUTICALS INC ownership

INMED PHARMACEUTICALS INC's ticker is and the CUSIP is 457637601. A total of 10 filers reported holding INMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of INMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$40
+14.3%
61
+45.2%
0.00%
Q2 2023$35
-18.6%
42
+2.4%
0.00%
Q1 2023$4341
-44.6%
0.00%
Q4 2022$074
-2.6%
0.00%
Q3 2022$0760.00%
Other shareholders
INMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TD Waterhouse Canada Inc. 85$1250.00%
ROYAL BANK OF CANADA 11$00.00%
Advisory Services Network, LLC 6$60.00%
TCI Wealth Advisors, Inc. 5$60.00%
UBS Group AG 2,622$2,8320.00%
AllSquare Wealth Management LLC 21$230.00%
OSAIC HOLDINGS, INC. 41$430.00%
BANK OF AMERICA CORP /DE/ 1,822$1,9680.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
TORONTO DOMINION BANK 2$00.00%
View complete list of INMED PHARMACEUTICALS INC shareholders